Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03976999

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical datas to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to epithetial ovarian cancer, Fallopian tube cancer and Primitive peritoneal cancer.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Carcinoma, Ovarian Epithelial Abdominal Neoplasms Adnexal Diseases Carcinoma Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Fallopian Tube Diseases Fallopian Tube Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Ovarian Diseases Ovarian Neoplasms Peritoneal Diseases Peritoneal Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ICM - Institut régional du Cancer Montpellier

Montpellier, 34298, France

Location status: Recruiting

Location contact

BLEUSE Jean-Pierre, MD

CONTACT

[email protected]

0467613102 ext. +33

About this study

A Clinical and Biological Database is a collection of reliable, prospective and representative datas.

This collection, provided to the scientific community, will help to develope research programs such as :

  • Cinicals and biological predictive factors of treatments response
  • Identification of biological tumoral markers associate with survival
  • Identification of prognosic factors after recidivism
  • Diagnostics tests optimisation and follow-up from blood samples ( Circulating Tumor Cells (CTC) )
  • Developing strong preclinical models. Those models would be later used to test alternative treatments and would help to identify new biomarkers

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 or older
  • Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer
  • Patient eligible for, at least, one surgery and a chemotherapy
  • Patient having given his informed, written and express consent

Exclusion criteria

  • Patient not affiliated to a social protection scheme
  • Pregnant and / or nursing women
  • Subject under tutelage, curatorship or safeguard of justice
  • Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons

Treatment and study plan

Biological collection

Other
  • Blood samples collected at different times : Before treatment (T1) , after chemotherapy (T2), after interval surgery (T3) and after cancer reccurence (T4)
  • Tissue samples (tumor tissue and healthy tissue) collected during the surgery

Primary outcomes

  1. Proportion of patients who gave their consent to participate in the study

    Time frame: Until the study completion : 3 years

    The proportion of patients who consent to participate in the study among the screened patients

Study contacts

Contact information is provided by the study sponsor or research team.

Aurore MOUSSION

CONTACT

[email protected]

+33 4 67 61 31 02

Sponsors and collaborators

Lead sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Other

Registry information

Official study title

Development of a Prospective and Monocentric Cinical and Biological Database in Epithelial Ovarian Cancer, Fallopian Tube Cancer and Primitive Peritoneal Cancer

Acronym: BCBOvaire

Important dates

Study start
2017
Primary completion
2027
Study completion
2032
First posted
Jun 6, 2019
Registry last updated
Feb 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.